openPR Logo
Press release

Nosocomial Pneumonia Pipeline 2024 | Aridis Pharmaceuticals, AstraZeneca, BioVersys, Clarametyx Biosciences, Johnsons & Johnsons Pharmaceutical LLC, PriCara Inc., Merck Sharp & Dohme LLC, Pfizer, Bayer, Nektar Therapeutics, Orlando Health Inc., Medline In

06-19-2024 05:54 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Nosocomial Pneumonia Pipeline

Nosocomial Pneumonia Pipeline

DelveInsight's, "Nosocomial Pneumonia Pipeline Insight 2024" report provides comprehensive insights about 13+ companies and 13+ pipeline drugs in the Nosocomial Pneumonia pipeline landscape. It covers the Nosocomial Pneumonia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Nosocomial Pneumonia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key Takeaways from the Nosocomial Pneumonia Pipeline Report
• April 2024:- Pfizer- The purpose of this study is to learn about the safety and effectiveness of Zavicefta once released into the markets in Korea. This study is to learn about Zavicefta in patients with difficult types of infections in the abdomen, urinary tract and pneumonia which could have come from hospitalizations.
• April 2024:- University of Bari- PROACT study aims to resolve uncertainties to influence actual practice guidelines or public health policing regarding VAP prevention in ICU by using probiotics administration. The present study will be a multicenter, randomized, double-blind, placebo-controlled trial. Allocation will rely on a computer-based random number generator provided in a sequentially numbered, sealed, opaque envelope.
• DelveInsight's Nosocomial Pneumonia pipeline report depicts a robust space with 13+ active players working to develop 13+ pipeline therapies for Nosocomial Pneumonia treatment.
• The leading companies working in the Nosocomial Pneumonia Market include Aridis Pharmaceuticals, AstraZeneca, BioVersys, Clarametyx Biosciences, Johnsons & Johnsons Pharmaceutical LLC, PriCara Inc., Merck Sharp & Dohme LLC, Pfizer, Bayer, Nektar Therapeutics, Orlando Health Inc., Medline Industries, Cubist Pharmaceuticals LLC, Peninsula Pharmaceuticals Inc., and others.
• Promising Nosocomial Pneumonia Pipeline Therapies in the various stages of development include Ceftolozane/Tazobactam, meropenem (active comparator), Amikacin inhalation solution (BAY41-6551), and others.

Request a sample and discover the recent advances in Nosocomial Pneumonia Treatment Drugs @ Nosocomial Pneumonia Pipeline Report- https://www.delveinsight.com/report-store/nosocomial-pneumonia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

In the Nosocomial Pneumonia pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Nosocomial pneumonia collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Nosocomial Pneumonia Overview
Nosocomial pneumonia or hospital-acquired pneumonia (HAP) is defined as pneumonia that occurs 48 hours or more after hospital admission and not incubating at the admission time. HAP occurs at a rate of 5 to 10 per 1000 hospital admissions and is considered the most common cause of hospital-acquired infection in Europe and the United States.

Find out more about Nosocomial Pneumonia Therapeutics Assessment @ Nosocomial Pneumonia Preclinical and Discovery Stage Products- https://www.delveinsight.com/sample-request/nosocomial-pneumonia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Nosocomial Pneumonia Emerging Drugs Profile
• Tosatoxumab: Aridis Pharmaceuticals
• Suvratoxumab: AstraZeneca
• Rifabutin: BioVersys
• CMTX 101 : Clarametyx Biosciences

Nosocomial Pneumonia Pipeline Therapeutics Assessment
There are approx. 13+ key companies which are developing the Nosocomial Pneumonia therapies. The Nosocomial Pneumonia companies which have their Nosocomial Pneumonia drug candidates in the most advanced stage, i.e. phase III include, Aridis Pharmaceuticals.

DelveInsight's Nosocomial Pneumonia Pipeline Report covers around 13+ products under different phases of clinical development like
• Late stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I) along with the details of
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Nosocomial Pneumonia pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intravenous
• Subcutaneous
• Oral
• Intramuscular

Nosocomial Pneumonia Pipeline Products have been categorized under various Molecule types such as
• Monoclonal antibody
• Small molecule
• Peptide

Learn more about the emerging Nosocomial Pneumonia Pipeline Therapies @ Nosocomial Pneumonia Clinical Trials Assessment- https://www.delveinsight.com/sample-request/nosocomial-pneumonia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Nosocomial Pneumonia Pipeline Report
• Coverage- Global
• Nosocomial Pneumonia Therapeutic Assessment by Product Type: Mono, Combination, Mono/Combination
• Nosocomial Pneumonia Therapeutic Assessment by Clinical Stages: Discovery, Pre-clinical, Phase I, Phase II, Phase III
• Nosocomial Pneumonia Companies- Aridis Pharmaceuticals, AstraZeneca, BioVersys, Clarametyx Biosciences, Johnsons & Johnsons Pharmaceutical LLC, PriCara Inc., Merck Sharp & Dohme LLC, Pfizer, Bayer, Nektar Therapeutics, Orlando Health Inc., Medline Industries, Cubist Pharmaceuticals LLC, Peninsula Pharmaceuticals Inc., and others.
• Nosocomial Pneumonia Pipeline Therapies- Ceftolozane/Tazobactam, meropenem (active comparator), Amikacin inhalation solution (BAY41-6551), and others.

Dive deep into rich insights for new drugs for Nosocomial Pneumonia Treatment, Visit @ Nosocomial Pneumonia Market Drivers and Barriers, and Future Perspective- https://www.delveinsight.com/sample-request/nosocomial-pneumonia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Introduction
2. Executive Summary
3. Nosocomial Pneumonia: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Nosocomial Pneumonia- DelveInsight's Analytical Perspective
7. Late Stage Products (Phase III)
8. Tosatoxumab: Aridis Pharmaceuticals
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. Suvratoxumab: AstraZeneca
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Rifabutin : BioVersys
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. CMTX 101 : Clarametyx Biosciences
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Nosocomial Pneumonia Key Companies
21. Nosocomial Pneumonia Key Products
22. Nosocomial Pneumonia- Unmet Needs
23. Nosocomial Pneumonia- Market Drivers and Barriers
24. Nosocomial Pneumonia- Future Perspectives and Conclusion
25. Nosocomial Pneumonia Analyst Views
26. Nosocomial Pneumonia Key Companies
27. Appendix

For further information on the Nosocomial Pneumonia Pipeline therapeutics, reach out to Nosocomial Pneumonia Unmet Needs and Analyst Views- https://www.delveinsight.com/sample-request/nosocomial-pneumonia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

List of Important Links-
Uveitis Market- https://www.delveinsight.com/report-store/uveitis-market
Hidradenitis Suppurativa Market- https://www.delveinsight.com/report-store/hidradenitis-suppurativa-market
Peripheral T-cell Lymphoma Market- https://www.delveinsight.com/report-store/peripheral-t-cell-lymphoma-ptcl-market
Glaucoma Market- https://www.delveinsight.com/report-store/glaucoma-market
Retinitis Pigmentosa Market- https://www.delveinsight.com/report-store/retinitis-pigmentosa-market
Oropharyngeal Cancer Market- https://www.delveinsight.com/report-store/oropharyngeal-cancer-market
Thyroid Cancer Market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Paranasal Sinus Cancer Market- https://www.delveinsight.com/report-store/paranasal-sinus-cancer-market
Castration-resistant Prostate Cancer Market- https://www.delveinsight.com/report-store/castration-resistant-prostate-cancer-crpc-market
Opioid Withdrawal Syndrome Market- https://www.delveinsight.com/report-store/opioid-withdrawal-syndrome-market
Complicated Urinary Tract Infections Market- https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market
Cervical Dystonia Market- https://www.delveinsight.com/report-store/cervical-dystonia-market
Schizophrenia Market- https://www.delveinsight.com/report-store/schizophrenia-market-insight
Focal Segmental Glomerulosclerosis Market- https://www.delveinsight.com/report-store/focal-segmental-glomerulosclerosis-fsgs-market
Obstructive Sleep Apnea Market- https://www.delveinsight.com/report-store/obstructive-sleep-apnea-osa-market
Severe Hypertriglyceridemia Market- https://www.delveinsight.com/report-store/severe-hypertriglyceridemia-shtg-market
Short Bowel Syndrome Market- https://www.delveinsight.com/report-store/short-bowel-syndrome-market
Complement 3 Glomerulopathy Market- https://www.delveinsight.com/report-store/complement-3-glomerulopathy-c3g-market
Aplastic Anemia Market- https://www.delveinsight.com/report-store/aplastic-anemia-market
Nephrotic Syndrome Market- https://www.delveinsight.com/report-store/nephrotic-syndrome-market
Pulmonary Arterial Hypertension Market- https://www.delveinsight.com/report-store/pulmonary-arterial-hypertension-market
Hemophilia A Market- https://www.delveinsight.com/report-store/hemophilia-a2030-market
Complicated Urinary Tract Infections Market- https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website:- https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nosocomial Pneumonia Pipeline 2024 | Aridis Pharmaceuticals, AstraZeneca, BioVersys, Clarametyx Biosciences, Johnsons & Johnsons Pharmaceutical LLC, PriCara Inc., Merck Sharp & Dohme LLC, Pfizer, Bayer, Nektar Therapeutics, Orlando Health Inc., Medline In here

News-ID: 3543725 • Views:

More Releases from DelveInsight Business Research LLP

Hidradenitis Suppurativa Drugs Market Size 2034 | Inflarx, Novartis Pharmaceuticals, Incyte Corporation, UCB Biopharma, Janssen Pharmaceuticals, Novartis Pharmaceuticals, Amgen, Chemocentryx, Priovant Therapeutics, Pfizer, Anaptysbio, Abbvie, Acelyrin, Ac
Hidradenitis Suppurativa Drugs Market Size 2034 | Inflarx, Novartis Pharmaceutic …
DelveInsight's "Hidradenitis Suppurativa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Hidradenitis Suppurativa, historical and forecasted epidemiology as well as the Hidradenitis Suppurativa market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan. Key Takeaways from the Hidradenitis Suppurativa Market • Currently only HUMIRA is approved for the treatment of moderate to severe hidradenitis suppurativa with mode stefficacy
Glaucoma Drugs Market Size 2032 | Allergan, Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical Co., Ltd., D.Western Therapeutics Institute (DWTI), Kowa Ltd., Alcon, Senju Pharmaceuticals and Otsuka Pharmaceuticals Co. Ltd., TearClear, Per
Glaucoma Drugs Market Size 2032 | Allergan, Sun Pharma Advanced Research Company …
DelveInsight's "Glaucoma Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the Glaucoma, historical and forecasted epidemiology and the Glaucoma market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan. Key Takeaways from the Glaucoma Market • According to DelveInsight's analysis, the total diagnosed prevalent cases of Glaucoma in 7MM were found to be 7,045,443 in 2022 and are
Retinitis Pigmentosa Drugs Market Size 2032 | Johnson & Johnson Innovative Medicine, MeiraGTx, Beacon Therapeutics, Nanoscope Therapeutics, Gensight Biologics, 4D Molecular Therapeutics, Coave Therapeutics, Ocugen, Bionic Sight, jCyte, Endogena Therapeuti
Retinitis Pigmentosa Drugs Market Size 2032 | Johnson & Johnson Innovative Medic …
DelveInsight's "Retinitis Pigmentosa Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of historical and forecasted epidemiology as well as the Retinitis Pigmentosa market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan. Key Takeaways from the Retinitis Pigmentosa Market Report • July 2024:- Janssen Pharmaceuticals- The purpose of the study is to assess the safety and tolerability of bilateral subretinal
Peanut Allergy Drugs Market Size 2032 | Parexel, Regeneron Pharmaceuticals, Sanofi, Aimmune Therapeutics Inc., AnaptysBio Inc., DBV Technologies, Aravax Pty Ltd, Astellas Pharma, Vedanta Biosciences Inc., Novartis Pharmaceuticals, Genentech Inc., and othe
Peanut Allergy Drugs Market Size 2032 | Parexel, Regeneron Pharmaceuticals, Sano …
DelveInsight's "Peanut Allergy Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Peanut Allergy, historical and forecasted epidemiology as well as the Peanut Allergy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Key Takeaways from the Peanut Allergy Market Report • The increased number of peanut allergy cases, along with the emerging treatment, is likely to contribute directly to the

All 5 Releases


More Releases for Nosocomial

Nosocomial Infection Treatment Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Nosocomial Infection Treatment Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Nosocomial Infection Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019.
Nosocomial Infections Pipeline Insight Report 2017- Market Research Hub
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Nosocomial Infections-Pipeline Insights, 2017”, report provides comprehensive insights of the ongoing therapeutic research and development across Nosocomial Infections. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Nosocomial Infections by development stage, therapy type, route of
Rising Prevalence Of Nosocomial Infections And Increased Number Of Surgeries To …
The global steam autoclaves market is marked by intense competitive rivalry and high entry barriers for new vendors, typical of markets featuring high consolidation, reports a recent study by Transparency Market Research (TMR). The oligopolistic market witnesses the dominance of companies such as STERIS, Getinge Group, and Johnson & Johnson, which collectively held close to two-third of the overall market in 2015. Obtain Report Details @ http://www.transparencymarketresearch.com/steam-autoclave-market.html The presence of a very
New Report: Global Nosocomial Infections Market
MarketResearchReports.Biz presents this most up-to-date research on "Nosocomial Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" Report, Nosocomial Infections-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Nosocomial Infections Report is to understand the market and pipeline status of the drugs around the Nosocomial
01-30-2017 | Health & Medicine
TMR
Global Hospital Acquired Infection Treatment Market: Growing Geriatric Populatio …
The staggering increase in the geriatric population across the world is working as a primary driver for the global hospital acquired infection treatment market, especially in developed nations from Europe. The market is also being propelled by the growing prevalence of nosocomial infections within the neonatal population, coupled by a general lack of efficient surveillance systems that can be used to detect HAIs. Emerging economies are known to be ripe
Rising Prevalence of Nosocomial Infections and Increased Number of Surgeries to …
Rising Prevalence of Nosocomial Infections and Increased Number of Surgeries to Drive Adoption of Steam Autoclave Systems Globally | Researchmoz.us Researchmoz added Most up-to-date research on "Steam Autoclave Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" to its huge collection of research reports. Autoclaves play a vital role in sterilization of health care waste in hospitals, health care organizations, and academics. Medical devices require autoclaving after